EUA
DxTerity SARS-CoV-2 RT PCR CE Test
FDA Emergency Use Authorization · DxTerity Diagnostics, Inc. · Feb 17, 2023
Key facts
| Product | DxTerity SARS-CoV-2 RT PCR CE Test |
|---|---|
| Company | DxTerity Diagnostics, Inc. |
| Product type | RT-PCR, Home Collection, Saliva, Multiple Targets |
| Date | Feb 17, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: